| 000 | 01099 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516060714.0 | ||
| 264 | 0 | _c20120126 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1558-5042 | ||
| 024 | 7 |
_a10.1016/j.soc.2011.07.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, Melissa H | |
| 245 | 0 | 0 |
_aRole of adjuvant chemotherapy in NSCLC (stages I to III). _h[electronic resource] |
| 260 |
_bSurgical oncology clinics of North America _cOct 2011 |
||
| 300 |
_a757-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aBueno, Raphael | |
| 773 | 0 |
_tSurgical oncology clinics of North America _gvol. 20 _gno. 4 _gp. 757-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.soc.2011.07.011 _zAvailable from publisher's website |
| 999 |
_c21219964 _d21219964 |
||